Experienced Lab Manager Appointed to Strengthen ACM Global’s Research and Development Efforts

Rochester, NY, Aug. 26, 2015 – ACM Global Central Laboratory, a diagnostic central laboratory delivering high-quality testing services that optimize clinical trial outcomes, is pleased to announce that Dr. Beverly Riley has been appointed as Research and Development Manager at its York facility. Prior to joining ACM, Dr. Riley led the operational management of several laboratories within St. James Hospital and directed the verification of new assays at Salford Royal NHS Foundation Trust. Her responsibilities at ACM include advising on the introduction of new assays and instrumentation, reviewing client protocols, and supporting the project management and business development teams.

“We are excited to welcome Dr. Riley to our York facility, strengthening our research and development efforts with her vast career and educational expertise,” said Jerry Boxall, Managing Director, ACM Europe and Asia. “At the core of her role as Research and Development Manager, Dr. Riley is responsible for providing scientific and technical support in the methodology and instrumentation of testing strategies, making her impressive experience in assay development and thorough understanding of industry regulations crucial assets.”

Dr. Riley accumulated her extensive educational background at the University of Sheffield where she earned a bachelor’s degree in biomedical science, a Ph.D in pharmacology, and a master’s degree in pathological sciences. Most recently, she served as Laboratory Manager of Clinical and Biomedical Proteomics at the University of Leeds and Technical Head for the Department of Immunology at Salford Royal NHS Foundation Trust.

About ACM Global Central Laboratory
ACM Global Central Laboratory specializes in delivering high quality central laboratory testing services designed to optimize clinical trial outcomes. Through a powerful combination of robust global capabilities, operational and scientific expertise and unsurpassed service, ACM Global acts as an extension of our clients’ clinical teams to develop and execute Smarter Testing strategies that deliver reliable outcomes for their clinical development programs. Operating in more than 60 countries, ACM Global’s analytical team performs more than 15 million diagnostic tests each year from a test menu with more than 1,500 tests spanning all medical disciplines, including pathology, microbiology and molecular diagnostics, flow cytometry, specialized biomarkers, and pharmacogenomics.

For more information, visit www.acmgloballab.com, our Central Labs in Focus blog or call +1 866 405 0400.


email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement